Development of a personalised substance use disorder treatment for people with mild intellectual disabilities or borderline intellectual functioning: An intervention mapping approach

Abstract

Background: The prevalence of Substance Use Disorder (SUD) in people with Mild Intellectual Disability and Borderline Intellectual Functioning (MID-BIF) is high and evidence-based treatment programs are scarce. The present study describes the development of a personalised SUD treatment for people with MID-BIF. Method: The personalised SUD treatment is developed according to the steps of the Intervention Mapping approach, based on literature review, theoretical intervention methods, clinical experience and consultation with experts in the field of addiction and intellectual disability care. Results: We developed a treatment manual called Take it Personal!+. Take it Personal!+ aims to reduce substance use, is based on motivational interviewing and cognitive behavior therapy and personalised based on the client's personality profile. Furthermore, an mHealth application supports the treatment sessions. Conclusion: Take it Personal!+ is the first personalised SUD treatment for individuals with MID-BIF. Future research should test the effectiveness of Take it Personal!+ in reducing SU.

The feasibility of daily monitoring in adolescents and young adults with mild intellectual disability or borderline intellectual functioning

“…Our compliance rates are comparable to those found in other daily diary studies in the same (Gosens et al, 2023) and different clinical populations (Czyz et al, 2018; Jones et al, 2019; Schreuder et al, 2023; Vachon et al, 2016; Welch et al, 2022), and are in line with general recommendations for EMA research (Trull & Ebner‐Priemer, 2020). Moreover, a considerably higher compliance was observed than that of the EMA study with adults with a moderate to mild intellectual disability (Wilson et al, 2020).…”

“…Gosens et al (2020) were then the first to use daily dairy sampling through mobile phones in 12 young persons with a mild intellectual disability or borderline intellectual functioning who followed a treatment for problematic substance use. On average, they adhered to 71% of their diaries during a period ranging from 2 to 12 months depending on treatment duration (Gosens et al, 2023).…”

The feasibility of daily monitoring in adolescents and young adults with mild intellectual disability or borderline intellectual functioning

“…Our compliance rates are comparable to those found in other daily diary studies in the same (Gosens et al, 2023) and different clinical populations (Czyz et al, 2018;Jones et al, 2019;Schreuder et al, 2023;Vachon et al, 2016;Welch et al, 2022), and are in line with general recommendations for EMA research (Trull & Ebner-Priemer, 2020). Moreover, a considerably higher compliance was observed than that of the EMA study with adults with a moderate to mild intellectual disability (Wilson et al, 2020).…”

Patients with cognitive deficits and substance use disorders, a clinical population in need of focused attention

“…In addition, they may experience more severe mental, physical, and social consequences from substance use than members of other groups ( 2 ). Second, individuals with impaired intellectual functioning are likely to experience barriers to accessing substance abuse treatment ( 22 , 23 ). Third, although traditionally identified and treated in intellectual disability (ID) services, recent studies indicate a large unidentified population of patients with premorbid intellectual impairment in facilities offering treatment for SUD with prevalence rates reaching up to 39% ( 12 , 21 , 24 ).…”